-
|
-
All Cancer Research Products
| Cat. No. | Product Description | Application | Quantity | Price | Cart |
|---|---|---|---|---|---|
| HS-537 003 | CD38, rabbit, polyclonal, affinity purifiedaffinity | WB IHC IHC-P (FFPE) | 50 µg | $375.00 |   |
| HS-493 017 | CD39, rat, monoclonal, purified IgG IgG mouse specific | WB IHC IHC-P (FFPE) | 100 µg | $420.00 | |
| HS-493 117 | CD39, rat, monoclonal, purified IgG IgG human specific | ICC IHC-P (FFPE) | 100 µg | $420.00 | |
| HS-427 003 | CD45, rabbit, polyclonal, affinity purifiedaffinity human specific | WB ICC IHC-P (FFPE) | 50 µg | $375.00 | |
| HS-427 117 | CD45, rat, monoclonal, purified IgG IgG human specific | IHC-P (FFPE) | 100 µg | $420.00 | |
| HS-515 003 | CD55, rabbit, polyclonal, affinity purifiedaffinity mouse specific | WB IHC IHC-P (FFPE) | 50 µg | $375.00 | |
| HS-460 003 | CD68, rabbit, polyclonal, affinity purifiedaffinity | WB IHC IHC-P (FFPE) | 50 µg | $375.00 | |
| HS-460 004 | CD68, Guinea pig, polyclonal, antiserumantiserum | IHC IHC-P (FFPE) | 100 µl | $355.00 | |
| HS-460 008 | CD68, rabbit, monoclonal, recombinant IgGrecombinant IgG human specific | WB IHC-P (FFPE) | 100 µl | $420.00 | |
| HS-460 017 | CD68, rat, monoclonal, purified IgG IgG human specific | WB ICC IHC IHC-P (FFPE) | 200 µl | $420.00 | |
| HS-492 003 | CD73, rabbit, polyclonal, affinity purifiedaffinity mouse specific | IHC IHC-P (FFPE) | 50 µg | $375.00 | |
| 259 002 | Chromogranin A, rabbit, polyclonal, antiserumantiserum discontinued soon, replacement: 259 003 | WB | 200 µl | $360.00 | |
| 259 003 | Chromogranin A, rabbit, polyclonal, affinity purifiedaffinity K.O. | WB ICC IHC IHC-P (FFPE) | 50 µg | $460.00 | |
| 259-0P | Chromogranin A, control proteincontrol protein | 100 µg | $110.00 | | |
| HS-501 003 | CLEC4F, rabbit, polyclonal, affinity purifiedaffinity C-terminal | WB IHC IHC-P (FFPE) | 50 µg | $375.00 | |
Certificates
ISO 9001 2015 Quality Management System and Green Lab Platinum certification level for sustaining laboratory processes.
Newsletter
Sign up for our newsletter and get the latest updates and news.